期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌激素治疗研究进展 被引量：5

原文传递
导出
摘要 随着乳腺癌激素作用的分子基础逐渐明了 ,在治疗中确立了检测激素受体来指导用药 ,且新型的激素药物不断开发问世 ,使乳腺癌的激素治疗在近 30年中有了本质的发展 ,乳腺癌的疗效进一步提高。
作者 刘鹏熙 唐利立
机构地区 中南大学湘雅医院肿瘤科
出处 《国外医学（生理病理科学与临床分册）》 2002年第3期305-307,共3页 Foreign Medical Sciences(Pathophysiology and Clinical Medicine)
关键词 乳腺肿瘤 激素治疗 治疗药物 联合用药 序贯用药 乳腺癌 研究进展
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Kurebayashi J, Sonoo H, Inaji H, et al. Endocrine therapies for patients with recurrent breast cancer: predictive factors for responses to first- and second-line endocrine therapies[ J ]. Oncology, 2000,59 (suppl 1 ): 31- 37.
  • 2Buzdar AU, Hortobagyi GN. Recent advances in adjuvant therapy of breast cancer[J]. Semin Oncol, 1999,26(4 suppl 12) :21 - 27.
  • 3Hamilton A, Piccart M. The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer[J ]. Ann Oncol, 1999,10(4) :377 -384.
  • 4Sonoo H, Kurebayashi J. Predictive factors for response to endocrine therapy in patients with recurrent breast cancer[J]. Breast Cancer,2000,7(4) :297 - 301.
  • 5Lonning PE. Clinico-pharmacological aspects of different hormone treatments[J]. Eur J Cancer, 2000,36(Suppl 4) :81 - 82.
  • 6Bajetta E, Zilembo N, Bichisao E, et al. Steroidal aromatase inhibitors in elderly patients[J]. Crit Rev Oncol Hematol, 2000, 33 (2): 137 -142.
  • 7Howell A. Faslodex (ICI 182780). an oestrogen receptor downregulator [J].Eur J Cancer, 2000, 36( suppl 4):87-88.
  • 8Prestwood KM, Gunness M, Muchmore DB, et al. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women[J].J Clin Endocrinol Metab, 2000,85(6):2197-2202.
  • 9Roe EB, Chiu KM, Arnaud CD. Selective estrogen receptor modulators and postmenopausal health[J] .Adv Intern Med, 2000,45:259-278.
  • 10Tremblay A, Tremblay GB, Labrie C, et al. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta[J]. Endocrinology, 1998,139(1):111 - 118.

同被引文献38

  • 1王琳.上海市杨浦区1983～2001年常见恶性肿瘤发病趋势[J].中国肿瘤,2004,13(11):694-695. 被引量：12
  • 2俞亚静.三苯氧胺在乳腺癌病人中的应用[J].安徽医药,2005,9(8):628-629. 被引量：8
  • 3Shibuya K,Mathers CD,Boschi-Pinto C,et al.Global and regional estimates of cancer morality and incidence by site:Ⅱ.results for the global burden of disease 2000[J].BMC Cancer,2002,2:37.
  • 4Karmofsky DA,Burchenal JH.The clinical evaluation of chemotherapeutic agents in cancer[A].In:McLoad CM,ed.Evaluation of chemotherapeutic agents[M].New York:Columbia Urtiversity Press,1949.191-205.
  • 5Saad F,Gleason DM,Murray R,et al.A randomized placebocontrolled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma[J].J Natl Cancer Inst,2002,94(19):1458-1468.
  • 6Meakin JW, Hayward JL, Panzarella T, et al. Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast[J]. Breast Cancer Res Treat, 1996, 37: 11-18.
  • 7徐叔云.临床用药指南[M].修订版.合肥:安微科技出版社.1997:1181.
  • 8Pritchard KI. Endocrine therapy of advanced disease : Analysis and implications of the existing data [J]. Clin Cancer Res, 2003, 91 (2) : 460-467.
  • 9Gazer JC, Coombes RC, Ford HT, et al. Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer[J]. Br J Cancer, 1996, 73 : 75-86.
  • 10Dixon JM, LoveCDB, Tucker S, et al. Letrozole as primary medical therapy for locally advanced and large operable breast cancer [J].Proc ASCO, 1998, 17: 104a.

引证文献5

二级引证文献11

国外医学（生理病理科学与临床分册）
2002年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部